4 days Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3Insider Monkey
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was down 3.72% for the quarter vs. +2.54% for the MSCI ACWI (in $A). It was down 5.59% in September vs. -0.35% for the index. The market rose in the […]
Pharmaceuticals · Regeneron Pharma (REGN)
X